Encompass Health CORP Form 4 insider transactions

Encompass Health's Chief Accounting Officer, Andrew L. Price, filed a Form 4 detailing future stock dispositions to cover tax obligations from restricted stock vesting.

An Encompass Health Corp executive disposed of shares to cover tax withholding obligations related to restricted stock vesting.

Encompass Health Corp's EVP & CFO, Douglas E. Coltharp, reported the disposition of shares to cover tax withholding obligations related to restricted stock vesting.

Encompass Health's Chief Operating Officer, Patrick W. Tuer, disposed of shares to cover tax withholding obligations from restricted stock vesting.

Encompass Health Corp's President and CEO, Mark J. Tarr, sold 140,000 shares of common stock on February 11, 2026, under a pre-arranged Rule 10b5-1 trading plan.

Encompass Health's EVP and Chief Operating Officer, Patrick William Tuer, reported a planned sale of 2,804 shares of common stock for February 10, 2026.

Encompass Health Director Cain A. Hayes received an award of 457 restricted stock units under the company's 2025 Omnibus Performance Incentive Plan.

Encompass Health Director Greg D. Carmichael acquired 28 shares of common stock through a routine restricted stock unit award tied to a dividend payment.

Encompass Health Corp. Director Joan E. Herman received 87 restricted stock units on January 15, 2026, as part of a routine dividend payment.

Encompass Health Director Leslye G. Katz received 87 restricted stock units as part of a dividend payment plan, increasing her direct beneficial ownership to 47,839 units.

Encompass Health Corp. Director Kevin J. O'Connor was awarded 17 restricted stock units on January 15, 2026, linked to a common stock dividend payment.

Encompass Health Director Nancy M. Schlichting received 40 restricted stock units as part of a dividend payment on January 15, 2026, increasing her direct beneficial ownership to 21,259 shares.

Encompass Health Corp. Director Terrance Williams received 28 restricted stock units on January 15, 2026, as part of a common stock dividend payment.

Encompass Health Director Edward M. Christie III increased his direct beneficial ownership of common stock through RSU awards and deferred compensation.

Encompass Health Corp. Director Christopher R. Reidy increased his beneficial ownership of common stock through RSU awards and a deferred stock investment plan.

Encompass Health Director Greg D. Carmichael received 23 restricted stock units on October 15, 2025, as part of a routine dividend payment plan.

Encompass Health Director Edward M Christie III increased his beneficial ownership of company stock and restricted stock units through a deferred compensation plan and dividend reinvestment.

Encompass Health Director Joan E. Herman acquired 73 restricted stock units following a common stock dividend payment on October 15, 2025.

Encompass Health Director Leslye G. Katz received 73 additional restricted stock units as part of a dividend payment, increasing her beneficial ownership to 47,752 shares.

Encompass Health Director Kevin J. O'Connor received 14 restricted stock units as part of a common stock dividend payment on October 15, 2025.

Encompass Health Director Christopher R. Reidy increased his direct beneficial ownership of company common stock through RSU awards and a deferred stock investment plan.

Encompass Health Corp. Director Nancy M. Schlichting acquired 33 additional restricted stock units tied to a common stock dividend payment.

Encompass Health Director Terrance Williams received 23 restricted stock units as part of a dividend payment plan.

Encompass Health's EVP and COO, Patrick W. Tuer, reported a planned sale of 1,020 shares of common stock for $123.59 per share, effective August 27, 2025, under a Rule 10b5-1 plan.

Encompass Health Corp's EVP & CFO, Douglas Coltharp, reported a transfer of shares by his spouse to a trust, a common personal financial planning move.

Encompass Health Corp. Director Christopher R. Reidy increased his beneficial ownership of company common stock through the acquisition of Restricted Stock Units and shares purchased via a deferred compensation plan.

Encompass Health Corp. Director Nancy M. Schlichting acquired 34 additional restricted stock units on July 15, 2025, as part of a dividend reinvestment program, increasing her total beneficial ownership to 21,186 units.

Encompass Health Corp. Director Kevin J. O'Connor was awarded 15 restricted stock units on July 15, 2025, as part of a dividend reinvestment program for non-employee directors.

Encompass Health Corp. Director Patricia Anne Maryland was awarded 24 additional restricted stock units (RSUs) on July 15, 2025, as part of a routine dividend reinvestment for non-employee directors.

Encompass Health Corp. Director Leslye G. Katz was credited with 74 restricted stock units (RSUs) on July 15, 2025, as part of a dividend reinvestment program.